Highlights in management of early stage non-small cell lung cancer

In October 2013, our sister Journal Translational Lung Cancer Research is going to launch a special issue on Management of Early Stage Non-Small Cell Lung Cancer. This special issue is guest-edited by Dr. Heather Wakelee, from Stanford Cancer Institute, Stanford University, USA. The scope of the special issue will be to provide cutting-edge literature on related fields and a platform for key experts to present their latest research results.

Apart from updates in surgical techniques, this special issue on Management of Early Stage Non-Small Cell Lung Cancer will present reviews on the importance of adequate lymph node sampling and on known prognostic biomarkers. We also have input on management for non-surgical patients, IR techniques, interventional pulmonology strategies and input from radiation oncologists. More interesting and exciting contents are coming up. Hope you will enjoy it.

Preview of the special issue:

• Interventional Pulmonology Approaches in diagnosis and treatment of early stage NSCLC
  Author: Arthur Sung
  Division of Pulmonary and Critical Care Medicine, New York Methodist Hospital, New York, USA


• Management of Ground Glass Opacities
  Author: Tetsuya Mitsudomi
  Aichi Cancer Center Hospital, Nagoya, Japan


• Potential Role of limited resections for small peripheral early stage NSCLC
  Author: Masahiro Tsuboi
  Department of Thoracic Surgery and Oncology, Tokyo Medical University and Hospital, Tokyo, Japan


• Towards Optimal Pathologic Staging of Resectable Non-Small Cell Lung Cancer
  Author: Raymond Osarogiagbon, Gail Darling
  Division of Oncology, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA


• Alternatives to Surgery in Early Stage Disease—SABR
  Author: Andrea Bezjak
  Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada


• Prognostic and Predictive Biomarkers in early stage NSCLC—tumor based approaches including gene signatures
  Author: Giorgio Scagliotti
  Department of Oncology, University of Turin, San Luigi Hospital, Regione Gonzale, Orbassano, Turin, Italy


• Prognostic and Predictive Biomarkers in early stage NSCLC—CTCs and serum/plasma markers
  Author: Fiona Blackhall
  Department of Medical Oncology, Christie Hospital, Manchester, UK


• Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
  Author: Enriqueta Felip-Font
  Oncology Service, Hospital Universitario de la Vall, Bacerlona


• Adjuvant Chemotherapy of Completely Resected Early Stage Non-Small Cell Lung Cancer (NSCLC)
  Author: Heather Wakelee, Ying Liang
  Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA


• Adjuvant Molecularly Targeted Therapy—Epidermal Growth Factor Tyrosine Kinase Inhibition and Beyond
  Author: Lecia Sequist, Joel Neal
  Massachusetts General Hospital Cancer Center, Boston, USA


• Adjuvant Immune-Based Therapy
  Author: Charles Butts
  Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada


• Post-Operative Radiation Therapy
  Author: Cécile Le Péchoux
  Institut Gustave Roussy, Radiotherapy Department, France


• Alternative to Surgery in Early Stage NSCLC—Interventional Radiologic Approaches
  Author: Bradley Pua
  New York-Presbyterian/Weill Cornell

Acknowledgements

Disclosure: The author declares no conflict of interest.